. . . . . . . . . . . . . "a(CHEBI:ceramide) -| p(RGD:Cebpb)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Immunoblot analysis revealed that C2 prevented increase in the level of nuclear C/EBPbeta by oltipraz, whereas the level of C/EBPbeta in total cell lysates was not changed. Increase in nuclear Nrf2 by t-BHQ was also prevented by C2 treatment. " . . "Selventa" . . . . "2014-07-03T14:32:27.772+02:00"^^ . . .